Regular Article CLINICAL TRIALS AND OBSERVATIONS Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia
نویسندگان
چکیده
Clinica Pediatrica, Università di Bologna, Ospedale “S. Orsola,” Bologna, Italy; Clinica Pediatrica, Università di Milano-Bicocca, Fondazione MBBM, Ospedale S. Gerardo, Monza, Italy; Clinica Oncoematologia Pediatrica, Università di Padova, Padova, Italy; Clinica Pediatrica, I Policlinico, II Università di Napoli, Napoli, Italy; Oncoematologia Pediatrica, Ospedale Infantile “Regina Margherita,” Torino, Italy; Oncoematologia Pediatrica, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy; Oncoematologia Pediatrica, Azienda Policlinico OVE, Catania, Italy; Oncoematologia Pediatrica, Ospedale Pausillipon, Napoli, Italy, Oncoematologia Pediatrica, IRCCS Istituto “Giannina Gaslini,” Genova, Italy; Clinica Pediatrica, Policlinico di Bari, Bari, Italy; Sezione di Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia, Università “Sapienza,” Roma, Italy; Oncoematologia Pediatrica, IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy; and Department of Pediatrics, Università di Pavia, Pavia, Italy
منابع مشابه
Prognostic Importance of Mutations in the rus Proto-Oncogenes in De Novo Acute Myeloid Leukemia
Mutations of the Nand K-ras genes are the most frequent genetic aberrations in acute myeloid leukemia (AML) and their detection in preleukemic conditions such as the myelodysplastic syndrome (MDS) suggests a role in the earliest phases of leukemogenesis. Despite these observations, little is known about the clinical importance of ras mutations in AML. We studied the clinical impact of ras mutat...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial
The primary objective of this phase 3 study was to determine whether postconsolidation immunotherapy with interleukin-2 (IL-2) and histamine dihydrochloride (HDC) improved the leukemia-free survival (LFS) of adult patients with acute myeloid leukemia (AML) in complete remission (CR). Three hundred twenty patients with AML (median age, 57 years; range, 18-84 years) were stratified by CR1 or subs...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children’s Cancer Study Group
Despite improvements in the treatment of acute myeloid leukemia (AML), approximately 50% of children die of the disease. Clinical trials in adult patients with AML indicate that idarubicin may have superior efficacy when compared to daunorubicin in the remission-induction phases of chemotherapy. We conducted consecutive clinical trials in children with newly diagnosed AML in which daunorubicin ...
متن کاملCLINICAL TRIALS AND OBSERVATIONS A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia
Older patients with acute myeloid leukemia (AML) have limited treatment options and a poor prognosis, thereby warranting novel therapeutic strategies. We evaluated the efficacy of lenalidomide as frontline therapy for older AML patients. In this phase 2 study, patients 60 years of age or older with untreated AML received highdose (HD) lenalidomide at 50 mg daily for up to 2 28-day cycles. If pa...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Acute mixed lineage leukemia in children: the experience of St Jude Children’s Research Hospital
To characterize the biology and optimal therapy of acute mixed-lineage leukemia in children, we reviewed the pathologic and clinical features, including response to therapy, of 35 patients with mixedlineage leukemia. The majority of cases (91%) had blasts cells that simultaneously expressed either T-lineage plus myeloid markers (T/myeloid, n 20) or B-lineage plus myeloid markers (B/myeloid, n 1...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013